In addition to some inflammation and pathological conditions [30,31], the versatile cytokine LCN2 has gained attention as a potential biomarker and a modulator of some human cancers, including breast [14], thyroid [32], colon [33], and pancreatic cancers [34]. This evidence concerns the gene LCN2 and familial pancreatic carcinoma.